OCLS: Rodman & Renshaw initate coverage
with "market outperform" rating & 12-month target price is set to $13.
newratings.com
....June 21 (newratings.com) - Analysts at Rodman & Renshaw initiate coverage of Oculus Innovative Sciences Inc (ticker: OCLS) with a "market outperform" rating. The 12-month target price is set to $13.
In a research note published this morning, the analysts mention that with the launch taking place in 2010, the sales of the company’s lead product, Microcyn®, for the treatment of diabetic foot ulcer infection alone are likely to exceed $1 billion by 2017. Oculus Innovative Sciences is likely to enter into a partnership for the product going forward, in order to exploit the commercial potential and receive royalties of 20% on net sales, the analysts say. ...
OCLS: Jan 2007 IPO (so watch for the 7/23/07 180 day unlock of restricted shares)
marketwatch.com
...priced its initial public offering at $8 a share, the bottom of its $8-$10 price range,...maker of products to prevent infection in wounds raised about $24 million by offering 3 million shares with Roth Capital Markets....
See: List in IPO Lockup Period Dates
ipohome.com
IPO WingedV pattern?
finance.yahoo.com
OCLS : the IPO Underwriters
ipohome.com
Roth Capital, Lead Manager
Maxim Group LLC, Co-Manager
Brookstreet Securities Corporation, Co-Manager
OCLS: 27-Mar-07
Roth Capital Initiated Oculus Innovative Sciences, Inc. (OCLS) with a Buy
newratings.com
....NEW YORK, March 27 (newratings.com) - Analysts at Roth Capital initiate coverage of Oculus Innovative Sciences Inc (ticker: OCLS) with a "buy" rating. The target price is set to $10....
06/13/07: Oculus' Microcyn technology in First Responder ''Pen-Like'' Applicator
re Oculus Innovative Sciences, Inc. (OCLS)
finance.yahoo.com
02.28.05 Oculus ( OCLS ) article in Forbes : Holy Water by Mary Ellen Egan
...Can a dash of electrically charged liquid heal life-threatening burns and wounds?...
forbes.com
OCLS and competitors KCI, SNN
finance.yahoo.com
Quotes: OCLS, KCI, SNN
finance.yahoo.com
OCLS website:
oculusis.com
Oculus Innovative Sciences, Inc. (OCLS) : profile
finance.yahoo.com
Oculus Innovative Sciences, Inc. engages in the development, manufacture, and marketing of a family of products intended to prevent and eliminate infection in acute and chronic wounds. |
